GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)
Clinical trial NCT04590547 · COMPLETED
Trial details
- NCT number
- NCT04590547
- Sponsor
- GeneOne Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-07
- Primary completion
- 2022-08-14
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.